Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

February 2, 1999

Study Completion Date

March 2, 2018

Conditions

Graft vs Host DiseaseHematologic Neoplasm

Trial Locations (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00001872 - Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease | Biotech Hunter | Biotech Hunter